Cargando…
The Role of the ACE2/MasR Axis in Ischemic Stroke: New Insights for Therapy
Ischemic stroke remains the leading cause of neurologically based morbidity and mortality. Current stroke treatment is limited to two classes of FDA-approved drugs: thrombolytic agents (tissue plasminogen activator (tPA)) and antithrombotic agents (aspirin and heparin), which have a narrow time-wind...
Autores principales: | Barzegar, Mansoureh, Stokes, Karen Y., Chernyshev, Oleg, Kelley, Roger E., Alexander, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615891/ https://www.ncbi.nlm.nih.gov/pubmed/34829896 http://dx.doi.org/10.3390/biomedicines9111667 |
Ejemplares similares
-
Human placenta mesenchymal stem cell protection in ischemic stroke is angiotensin converting enzyme‐2 and masR receptor‐dependent
por: Barzegar, Mansoureh, et al.
Publicado: (2021) -
Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19
por: Morganstein, Taylor, et al.
Publicado: (2021) -
Sex Difference in MasR Expression and Functions in the Renal System
por: Choopani, Samira, et al.
Publicado: (2022) -
Exercise intensities modulate ACE2/MasR/eNOS pathway in male Wistar rat's lung
por: Lestari, Yani Medina, et al.
Publicado: (2023) -
Hyaluronic acid/diminazene aceturate combination ameliorates osteoarthritic anomalies in a rodent model: a role of the ACE2/Ang1-7/MasR axis
por: Habib, Yasser H., et al.
Publicado: (2023)